118 related articles for article (PubMed ID: 29178686)
1. Memantine as an Augmentation Treatment for Schizophrenia: Limitations of Meta-Analysis for Evidence-Based Evaluation of Research.
Andrade C
J Clin Psychiatry; 2017; 78(9):e1307-e1309. PubMed ID: 29178686
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
[TBL] [Abstract][Full Text] [Related]
3. Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.
Kishi T; Matsuda Y; Iwata N
Psychopharmacology (Berl); 2017 Jul; 234(14):2113-2125. PubMed ID: 28508107
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of Antipsychotic Treatment with Memantine in Patients with Schizophrenia: A Systematic Review and Meta-Analysis.
Vayısoğlu S; Karahan S; Anıl Yağcıoğlu AE
Turk Psikiyatri Derg; 2019; 30(4):253-259. PubMed ID: 32594486
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia.
Lieberman JA; Papadakis K; Csernansky J; Litman R; Volavka J; Jia XD; Gage A;
Neuropsychopharmacology; 2009 Apr; 34(5):1322-9. PubMed ID: 19005465
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: an updated meta-analysis of randomized placebo-controlled trials.
Matsuda Y; Kishi T; Iwata N
J Psychiatr Res; 2013 Dec; 47(12):2018-20. PubMed ID: 24079776
[No Abstract] [Full Text] [Related]
7. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials.
Zheng W; Zhu XM; Zhang QE; Cai DB; Yang XH; Zhou YL; Ungvari GS; Ng CH; He SH; Peng XJ; Ning YP; Xiang YT
Schizophr Res; 2019 Jul; 209():12-21. PubMed ID: 31164254
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs and 5-HT₃ serotonin receptor antagonists as innovative antipsychotic augmentation treatments for schizophrenia.
Andrade C
J Clin Psychiatry; 2014 Jul; 75(7):e707-9. PubMed ID: 25093487
[TBL] [Abstract][Full Text] [Related]
9. Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.
Rezaei F; Mohammad-Karimi M; Seddighi S; Modabbernia A; Ashrafi M; Salehi B; Hammidi S; Motasami H; Hajiaghaee R; Tabrizi M; Akhondzadeh S
J Clin Psychopharmacol; 2013 Jun; 33(3):336-42. PubMed ID: 23609382
[TBL] [Abstract][Full Text] [Related]
10. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and nonpharmacological augmentation treatments for clozapine-resistant schizophrenia: A systematic review and network meta-analysis with normalized entropy assessment.
Yeh TC; Correll CU; Yang FC; Chen MH; Tseng PT; Hsu CW; Carvalho AF; Stubbs B; Thompson T; Chu CS; Yu CL; Il Shin J; Yang SN; Tu YK; Liang CS
Asian J Psychiatr; 2023 Jan; 79():103375. PubMed ID: 36470132
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials.
Andrade C; Kisely S; Monteiro I; Rao S
J Psychiatr Res; 2015 Jan; 60():14-21. PubMed ID: 25306261
[TBL] [Abstract][Full Text] [Related]
13. The effect of add-on memantine on positive, negative and depressive symptoms of schizophrenia: a doubleblind, randomized, controlled trial.
Omranifard V; Rajabi F; Mohammadian-Sichani M; Maracy MR
Actas Esp Psiquiatr; 2017 May; 45(3):108-15. PubMed ID: 28594056
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.
Veerman SR; Schulte PF; Deijen JB; de Haan L
Psychol Med; 2017 Jan; 47(2):363-375. PubMed ID: 27776560
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trials.
Kishi T; Mukai T; Matsuda Y; Moriwaki M; Iwata N
J Psychiatr Res; 2013 Nov; 47(11):1557-63. PubMed ID: 23899496
[TBL] [Abstract][Full Text] [Related]
16. [Memantine as an adjunctive therapy for schizophrenia negative symptoms].
Gama CS; Antunes P; Moser C; Belmonte-de-Abreu PS
Braz J Psychiatry; 2005 Sep; 27(3):257-8. PubMed ID: 16224621
[No Abstract] [Full Text] [Related]
17. Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study.
Krivoy A; Weizman A; Laor L; Hellinger N; Zemishlany Z; Fischel T
Eur Neuropsychopharmacol; 2008 Feb; 18(2):117-21. PubMed ID: 17728110
[TBL] [Abstract][Full Text] [Related]
18. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
Correll CU; Maayan L; Kane J; Hert MD; Cohen D
J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
[TBL] [Abstract][Full Text] [Related]
19. The Use of Statins for Antipsychotic Augmentation in Schizophrenia: Examination of Meta-Analyses With Flawed Methods and Conclusions.
Andrade C
J Clin Psychiatry; 2018 Sep; 79(5):. PubMed ID: 30256553
[TBL] [Abstract][Full Text] [Related]
20. Off-label use of memantine as adjunctive treatment in schizophrenia: a retrospective case series study.
John JP; Lukose A; Manjunath S
Pharmacopsychiatry; 2014 Sep; 47(6):202-9. PubMed ID: 25167200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
